Antimalarial evaluation of copper(II) nanohybrid solids: inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum

作者：Mohapatra Subash Chandra^*; Tiwari Hemandra Kumar; Singla Manisha; Rathi Brijesh; Sharma Arun; Mahiya Kuldeep; Kumar Mukesh; Sinha Saket; Chauhan Shyam Singh

来源：Journal of Biological Inorganic Chemistry, 2010, 15(3): 373-385.

DOI：10.1007/s00775-009-0610-9

• Copper(II) nanohybrids
• Antimalarial activity
• Malaria
• Plasmodium falciparum
• Plasmepsin II

A new class of copper(II) nanohybrid solids, LCu(CH3COO)(2) and LCuCl2, have been synthesized and characterized by transmission electron microscopy, dynamic light scattering, and IR spectroscopy, and have been found to be capped by a bis(benzimidazole) diamide ligand (L). The particle sizes of these nanohybrid solids were found to be in the ranges 5-10 and 60-70 nm, respectively. These nanohybrid solids were evaluated for their in vitro antimalarial activity against a chloroquine-sensitive isolate of Plasmodium falciparum (MRC 2). The interactions between these nanohybrid solids and plasmepsin II (an aspartic protease and a plausible novel target for antimalarial drug development), which is believed to be essential for hemoglobin degradation by the parasite, have been assayed by UV-vis spectroscopy and inhibition kinetics using Lineweaver-Burk plots. Our results suggest that these two compounds have antimalarial activities, and the IC50 values (0.025-0.032 mu g/ml) are similar to the IC50 value of the standard drug chloroquine used in the bioassay. Lineweaver-Burk plots for inhibition of plasmepsin II by LCu(CH3COO)(2) and LCuCl2 show that the inhibition is competitive with respect to the substrate. The inhibition constants of LCu(CH3COO)(2) and LCuCl2 were found to be 10 and 13 mu M, respectively. The IC50 values for inhibition of plasmepsin II by LCu(CH3COO)(2) and LCuCl2 were found to be 14 and 17 mu M, respectively. Copper(II) metal capped by a benzimidazole group, which resembles the histidine group of copper proteins (galactose oxidase, beta-hydroxylase), could provide a suitable anchoring site on the nanosurface and thus could be useful for inhibition of target enzymes via binding to the S1/S3 pocket of the enzyme hydrophobically. Both copper(II) nanohybrid solids were found to be nontoxic against human hepatocellular carcinoma cells and were highly selective for plasmepsin II versus human cathepsin D. The pivotal mechanism of antimalarial activity of these compounds via plasmepsin II inhibition in the P. falciparum malaria parasite is demonstrated.

• 出版日期2010-3
• 单位河北医科大学